Robert P. Stiller - 29 Dec 2021 Form 4 Insider Report for NOBLE ROMANS INC (NROM)

Role
10%+ Owner
Signature
/s/ Stephen Magowan, Attorney-in-fact for Robert P. Stiller
Issuer symbol
NROM
Transactions as of
29 Dec 2021
Transactions value $
-$5,147
Form type
4
Filing time
03 Jan 2022, 10:28:12 UTC
Previous filing
01 Oct 2021
Next filing
05 Jan 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NROM Common Stock Sale -$1,470 -3,932 -0.16% $0.3739 2,396,688 29 Dec 2021 Direct F1
transaction NROM Common Stock Sale -$1,166 -2,985 -0.12% $0.3907 2,393,703 30 Dec 2021 Direct F2
transaction NROM Common Stock Sale -$2,510 -6,353 -0.27% $0.3952 2,387,350 31 Dec 2021 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.3501 to $0.39. The undersigned undertakes to provide Noble Romans Inc. ("Noble"), any security holder of Noble or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.39 to $0.391. The undersigned undertakes to provide Noble, any security holder of Noble or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.39 to $0.44. The undersigned undertakes to provide Noble, any security holder of Noble or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.